Engineering E. coli Alkaline Phosphatase Yields Changes of Catalytic Activity,Thermal Stability and Phosphate Inhibition

To investigate the function of aspartic acid residue 101 and arginine residue 166 in the active site of Escherichia coli alkaline phosphatase (EAP), two single mutants D101S (Asp 101 &#77 Ser) and R166K (Arg 166 &#77 Lys) and a double mutant D101S/R166K of EAP were generated through site-directed mutagenesis based on over-lap PCR method. Their enzymatic kinetic properties, thermal stabilities and possible reaction mechanism were explored. In the presence of inorganic phosphate acceptor, 1 M diethanolamine buffer, the k cat for D101S mutant enzyme increased 10-fold compared to that of wild-type EAP. The mutant R166K has a 2-fold decrease of k cat relative to the wild-type EAP, but the double mutant D101S/R166K was in the middle of them, indicative of an additive effect of these two mutations. On the other hand, the catalytic efficiencies of mutant enzymes are all reduced because of a substantial increase of K m values. All three mutants were more resistant to phosphate inhibitor than the wild-type enzyme. The analysis of the kinetic data suggests that (1) the D101S mutant enzyme obtains a higher catalytic activity by allowing a faster release of the product; (2) the R166K mutant enzyme can reduce the binding of the substrate and phosphate competitive inhibitor; (3) the double mutant enzyme has characteristics of both quicker catalytic turnover number and decreased affinity for competitive inhibitor. Additionally, pre-steady-state kinetics of D101S and D101S/R166K mutants revealed a transient burst followed by a linear steady state phase, obviously different from that of wild-type EAP, suggesting that the rate-limiting step has partially change from the release of phosphate from non-covalent E-Pi complex to the hydrolysis of covalent E-Pi complex for these two mutants.     

Directed Evolution of E. coli Alkaline Phosphatase Towards Higher Catalytic Activity

Directed evolution was used to enhance the catalytic activity of E. coli alkaline phosphatase (EAP). Through two rounds of error-prone PCR and one round of DNA shuffling followed by a rapid, sensitive screening procedure, several improved variants were obtained. Their enzymatic kinetic properties, thermal stabilities and possible mechanism for the improvement were investigated. In 1.0 M Tris buffer, the specific activity of the most active EAP variant S2163 was 1500 units/mg protein, showing it to be 3.6 times more active than the D101S parent enzyme and ～40 times more active than the wild-type EAP. At the same time, the K_m value of the S2163 variant decreased to 1491 μM from the 2384 μM of the D101S. As a result, the k_cat/K_m ratio of this variant showed a 5.8-fold enhancement over that of D101S parent enzyme. Three activating amino acid substitutions, K167R, G180S and S374C, which were located far away from the center of the catalytic pocket, were identified by sequencing the genes encoding evolved enzymes. Possible explanations for the improvement of activity were analyzed.     

Directed Evolution of E. coli Alkaline Phosphatase Towards Higher Catalytic Activity

Directed evolution was used to enhance the catalytic activity of E. coli alkaline phosphatase (EAP). Through two rounds of error-prone PCR and one round of DNA shuffling followed by a rapid, sensitive screening procedure, several improved variants were obtained. Their enzymatic kinetic properties, thermal stabilities and possible mechanism for the improvement were investigated. In 1.0 M Tris buffer, the specific activity of the most active EAP variant S2163 was 1500 units/mg protein, showing it to be 3.6 times more active than the D101S parent enzyme and ∼40 times more active than the wild-type EAP. At the same time, the K_m value of the S2163 variant decreased to 1491 μM from the 2384 μM of the D101S. As a result, the k_cat/K_m ratio of this variant showed a 5.8-fold enhancement over that of D101S parent enzyme. Three activating amino acid substitutions, K167R, G180S and S374C, which were located far away from the center of the catalytic pocket, were identified by sequencing the genes encoding evolved enzymes. Possible explanations for the improvement of activity were analyzed.     

Chronic Cadmium Exposure Lead to Inhibition of Serum and Hepatic Alkaline Phosphatase Activity in Wistar Rats

Alkaline phosphatase (ALP) activity in the serum and liver from rats administered with cadmium (Cd) in drinking water was studied. After metal administration, Cd showed a time‐dependent accumulation in the liver, meanwhile metallothionein had a maximum increase at 1 month, remaining in this level until the end of the study. On the other hand, serum and liver ALP activity was decreased after 3 months exposure. To determine if Cd produced an inhibition on enzyme, apo‐ALP prepared from both nonexposed and exposed rats was reactivated with Zn, showing 60% more activity as compared with the enzyme isolated from nonexposed rats. In vitro assays showed that Cd‐ALP was partially reactivated with Zn; however, in the presence of cadmium, Zn‐ALP was completely inhibited. Kinetic studies indicate a noncompetitive inhibition by Cd; these results suggest that Cd can substitute Zn, and/or Cd can interact with nucleophilic ligands essential for the enzymatic activity.     

Characterization of Mutant HIV-1 Integrase Carrying Amino Acid Changes in the Catalytic Domain

To gain insight into the importance of conserved residues in the core domain of HIV-1 IN, we performed site-directed mutagenesis of the full-length enzyme, overexpressed the mutant proteins in E. coli, purified and analyzed their 3-processing, integration and disintegration activities in vitro. Change of E152V in the DD(35)E motif abolished all detectable activities of IN. Alteration of two highly conserved residues, P145 and K156, by isoleucine, resulted in a substantial loss or completely abolished the three activities of the enzyme. Mutant P90D weakly reduced the 3-processing but severely affected the two other IN activities. Results obtained from double and triple mutations, P90D/P145I and P145I/F185K/C280S, clearly suggest a crucial role of P145 in the catalytic function of IN, whereas the mutants V150E, L158F and L172M had no detectable effect on any of the IN activities. Taken together, these results allowed us to conclude that all the conserved amino acids in the core domain of IN are not equally important for catalytic functions: like D64, D116 and E152, our data suggest that P90, P145 and K156 are also essential for all three enzymatic activities of HIV-1 IN in vitro, whereas V150, L158 and L172 appear to be less critical.     

有机溶剂对缢蛏碱性磷酸酯酶分子构象和催化活力的影响

本文初步研究了三种有机溶剂甲醇、二甲基甲酰胺、二氧六环对缢蛏碱性磷酸酯酶(ALP)分子构象和催化活力的影响。发现在有机溶剂作用下,ALP的荧光发射光谱、紫外差光谱、园二色光谱都发生了显著的变化,而酶经甲醇、二甲基甲酰胺预处理后酶活力提高,经二氧六环预处理后活力下降,但当测活体系中有三种有机溶剂存在时,酶的活力却被大大抑制。     

E93R Substitution of Escherichia coli FtsZ Induces Bundling of Protofilaments,Reduces GTPase Activity,and Impairs Bacterial Cytokinesis

Recently, we found that divalent calcium has no detectable effect on the assembly of Mycobacterium tuberculosis FtsZ (MtbFtsZ), whereas it strongly promoted the assembly of Escherichia coli FtsZ (EcFtsZ). While looking for potential calcium binding residues in EcFtsZ, we found a mutation (E93R) that strongly promoted the assembly of EcFtsZ. The mutation increased the stability and bundling of the FtsZ protofilaments and produced a dominating effect on the assembly of the wild type FtsZ (WT-FtsZ). Although E93R-FtsZ was found to bind to GTP similarly to the WT-FtsZ, it displayed lower GTPase activity than the WT-FtsZ. E93R-FtsZ complemented for its wild type counterpart as observed by a complementation test using JKD7–1/pKD3 cells. However, the bacterial cells became elongated upon overexpression of the mutant allele. We modeled the structure of E93R-FtsZ using the structures of MtbFtsZ/Methanococcus jannaschi FtsZ (MjFtsZ) dimers as templates. The MtbFtsZ-based structure suggests that the Arg⁹³-Glu¹³⁸ salt bridge provides the additional stability, whereas the effect of mutation appears to be indirect (allosteric) if the EcFtsZ dimer is similar to that of MjFtsZ. The data presented in this study suggest that an increase in the stability of the FtsZ protofilaments is detrimental for the bacterial cytokinesis.     

大肠杆菌精氨酰－tRNA合成酶的Lys378和381的点突变研究

用点突变的方法将大肠杆菌精氨酰—ｔＲＮＡ合成酶（ＡｒｇＲＳ）的基因ａｒｇｓ上相应于Ｌｙｓ３７８和Ｌｙｓ３８１的密码ＡＡＡ分别变为两氨酸的密码ＧＣＡ和精氨酸的密码子ＣＧＴ,得到了４个ａｒｇｓ的突变体ａｒｇｓ３７８ＫＡ,ａｒｇｓ３７８ＫＲ,ａｒｇｓ３８１ＫＡ和ａｒｇｓ３８１ＫＲ,将它们分别连接到ｐＵＣ１８上,转入大肠杆菌ＴＧ１,在ＴＧ１转化子中,ＡｒｇＲＳ及其变种的表达量约为ＴＧ１中的１２０倍以上。结果表明Ｌｙｓ３７８为Ａｒｇ和Ａｌａ取代分别使活力下降０％和１０％;Ｌｙｓ３８１变为Ａｌａ和Ａｒｇ后,活力分别下降３３％和１０％左右。Ｌｙｓ３７８不为酶活力必需。Ｌｙｓ３８１部位的正电荷对酶活力是重要的。     

中国明对虾过氧化物还原酶基因在大肠杆菌中的重组表达、产物纯化及活性测定

过氧化物还原酶（Prx）是生物体内广泛存在的一类酶,在消除过氧化氢和抗氧化胁迫中起着重要的作用。本研究采用PCR扩增编码中国明对虾Prx成熟肽的基因,并克隆到大肠杆菌表达载体pCR®T7/NT TOPO® TA中进行体外重组表达。重组质粒转化大肠杆菌BL21 (DE3) pLysS后,经IPTG诱导表达产生包涵体形式的目的蛋白。对重组蛋白进行LC–ESI–MS分析,结果表明融合蛋白的四个肽段与中国明对虾Prx相应肽段完全一致。将重组蛋白通过金属螯合柱进行纯化,进而透析、复性,最后获得了具有较高过氧化物酶活性的重组Prx。中国明对虾Prx的成功表达,为深入研究其在中国明对虾免疫反应和抗氧化胁迫中的作用奠定了基础。     

蚯蚓纤溶酶基因P239的原核表达、纯化及活性测定

通过RT-PCR方法从蚯蚓(Lumbricus bimastus)中获得蚯蚓纤溶酶基因,命名为P-239,含有 852 个核苷酸,成熟肽编码 239 个氨基酸,通过Genbank 序列同源性比较,与已知的蚯蚓纤溶酶有一定的同源性,为首次获得的新基因.随后构建了pBV-220/P-239重组质粒,在大肠杆菌DH5α中进行原核表达,再经亲和层析柱纯化复性,其产物经活性测定,确定不仅具有激酶作用,而且具有直接溶栓活性.     

Exendin -4在大肠杆菌中的串联表达、纯化及活性鉴定

目的:完成钝尾毒蜥Exendin -4基因在大肠杆菌中的串联高效表达.方法:按照大肠杆菌偏爱密码子设计Exendin -4基因片段,利用同尾酶构建多拷贝串联的表达载体,于大肠杆菌BL21( DE3)中诱导表达,SDS - PAGE鉴定结果,表达产物Ni柱纯化后肠激酶切割,高效液相色谱及四级杆-飞行时间质谱纯化、鉴定,确定目标产物,作用胰岛瘤细胞INS -1检测胰岛素释放活性.结果:成功构建重组载体pET28a -(Exendin -4)n(n=2,4,6),且均获得可溶性表达产物,重组表达蛋白经切割、纯化、鉴定和制备,最终得到纯度98%的Exendin -4,其具有与标准品相似的促葡萄糖刺激的胰岛素释放活性.结论:试验成功利用串联表达方式制备有活性的Exendin -4,为下一步2型糖尿病治疗药物的研究奠定了基础.     

人细胞色素c基因在大肠杆菌中的克隆和表达及活性测定

通过PCR方法 ,从人胎儿心肌基因组DNA中得到precytc基因 (有 1个内含子 ) ,剔除内含子后 ,得到细胞色素c基因的编码序列 .测序结果表明 ,该基因与GenBank中报道的人细胞色素c基因核苷酸顺序完全一致 .将其插入原核表达载体pET3a的NdeⅠ和HindⅢ位点之间构建pET3a cytc重组质粒 ,并成功转化入E .coliBL2 1(DE3)中 .经IPTG诱导表达后 ,15 %SDS PAGE分析 ,可观察到1条与细胞色素c蛋白分子量相符的电泳条带 .Western印迹结果显示 ,该条带与小鼠抗人cytc单克隆抗体IgG2b发生特异反应 ,证实为人细胞色素c的前体蛋白 .体外使血红素与该前体蛋白结合生成完整的人细胞色素c蛋白 ,其耗氧量在不同浓度具有与反应时间的线性关系 ,为研究人细胞色素c结构和功能关系奠定了基础     

人血纤维蛋白溶酶原K5环的基因合成、表达、纯化与活性鉴定

 根据大肠杆菌遗传密码的偏爱性 ,人工合成人血纤维蛋白溶酶原 K5全基因 ,并在原核系统中以硫氧还蛋白融合蛋白的形式实现了高效表达 .重组蛋白通过 Ni2 +金属螯合层析得到初步纯化 ,通过肠激酶切割去除了融合标签 .应用鸡胚尿囊膜实验检测切割后的 rh K5的生物学活性 ,发现与对照组相比 ,rh K5能明显地降低血管管径、血管总面积以及血管总面积与视野面积的比值 ,表明切割后的产物具有显著抑制新生血管生成的生物学活性 .为进一步研究和开发抗血管生成药物奠定了基础 .     

重组人谷氧还蛋白1在大肠杆菌中表达条件的优化、纯化及活性检测

为进一步研究谷氧还蛋白1(Grx1)的生物学功能及作用机制,将已构建的pRSETA-Grx1融合蛋白表达载体在大肠杆菌BL21(DE3)菌株中表达,并优化表达条件,用SDS-PAGE和凝胶影像分析.结果表明,当菌体密度OD600为1.0时开始诱导,加入终浓度0.5mmol/LIPTG,37℃,110±5r/min振荡培养5h,重组蛋白为可溶性,表达量达30%以上.用Ni-NTA树脂亲和层析纯化重组蛋白,获得蛋白质纯度达90%以上;W estern印迹结果表明,该蛋白具有免疫活性;MTT结果显示,终浓度为10mg/LGrx1重组蛋白具有保护细胞抵御500μmol/LH2O2作用(P<0.01).     

Engineering of baker's yeasts, E. coli and Bacillus hosts for the production of Bacillus subtilis Lipase A

Lipases are versatile biocatalists showing multiple applications in a wide range of biotechnological processes. The gene lipA coding for Lipase A from Bacillus subtilis was isolated by PCR amplification, cloned and expressed in Escherichia coli, Saccharomyces cerevisiae and Bacillus subtilis strains, using pBR322, YEplac112 and pUB110-derived vectors, respectively. Lipase activity analysis of the recombinant strains showed that the gene can be properly expressed in all hosts assayed, this being the first time a lipase from bacterial origin can be expressed in baker's S. cerevisiae strains. An important increase of lipase production was obtained in heterologous hosts with respect to that of parental strains, indicating that the described systems can represent a useful tool to enhance productivity of the enzyme for biotechnological applications, including the use of the lipase in bread making, or as a technological additive.     

拟南芥海藻糖酶基因克隆及其在大肠杆菌中高效表达与功能研究

从拟南芥幼苗中提取RNA, 通过RT-PCR克隆得到海藻糖酶基因后, 将其构建到原核高效表达载体pET30a(+)上并在大肠杆菌BL21菌株中进行高效诱导表达, 继而对纯化得到的海藻糖酶蛋白进行活性检测和酶学特性研究。实验结果表明, 植物源的海藻糖酶基因在异体大肠杆菌中能够高效表达, 纯化获得的海藻糖酶蛋白在试管条件下具有较高的海藻糖水解活性, 其活性最适温度为45℃。通过GC-MS分离检测, 可以明显地看到酶反应过程中底物海藻糖和产物葡萄糖的含量随反应时间变化的消长关系, 这充分证明克隆基因在大肠杆菌中的表达产物具有海藻糖酶的功能。     

拟南芥海藻糖酶基因克隆及其在大肠杆菌中高效表达与功能研究

从拟南芥幼苗中提取RNA,通过RT-PCR克隆得到海藻糖酶基因后,将其构建到原核高效表达载体pET30a( )上并在大肠杆菌BL21菌株中进行高效诱导表达,继而对纯化得到的海藻糖酶蛋白进行活性检测和酶学特性研究.实验结果表明,植物源的海藻糖酶基因在异体大肠杆菌中能够高效表达,纯化获得的海藻糖酶蛋白在试管条件下具有较高的海藻糖水解活性,其活性最适温度为45℃.通过GC-MS分离检测,可以明显地看到酶反应过程中底物海藻糖和产物葡萄糖的含量随反应时间变化的消长关系,这充分证明克隆基因在大肠杆菌中的表达产物具有海藻糖酶的功能.     

单纯疱疹病毒1型囊膜糖蛋白gD在大肠杆菌中的表达、纯化及其免疫活性的鉴定

目的:在大肠杆菌中表达1型单纯疱疹病毒(HSV-1)囊膜糖蛋白gD,纯化重组蛋白并对其免疫活性进行鉴定。方法:将HSV-1 gD 基因克隆入原核表达载体pET-28b,利用异丙基-B-D-硫代吡喃半乳糖苷(IPTG)诱导重组质粒转化的大肠杆菌,探讨IPTG浓度、诱导时间、诱导温度对重组蛋白表达的影响;盐酸胍裂解变性包涵体,镍柱亲和层析法纯化gD蛋白,并对纯化后的蛋白进行透析复性;Western blot和ELISA检测gD蛋白的免疫活性。结果:酶切和测序结果表明gD基因克隆入pET-28b载体。该重组质粒转化的大肠杆菌经IPTG诱导后重组蛋白主要以包涵体形式存在,大小约40kDa。gD蛋白诱导表达的最佳条件为0.5mmol/L IPTG于37℃诱导8h。镍柱亲和层析法纯化获得的gD蛋白总量为3.1mg/L,透析复性后获得的gD蛋白总量为1.3mg/L,复性率为41.37%。Western blot及ELISA检测表明表达的gD蛋白具有免疫活性。结论:在大肠杆菌中表达并纯化获得具有免疫活性的HSV-1 gD蛋白,为进一步制备HSV-1诊断试剂和预防疫苗奠定了基础。     

人甲状旁腺素(1-34)衍生物在大肠杆菌中表达、纯化及其生物学活性

为研究Gly hPTH(1 34)衍生物的生物学活性 ,用重叠PCR方法合成编码hPTH(1 34)的DNA片段 ,克隆到融合表达载体pGEX 2T的缩短型谷胱甘肽转移酶基因GST6 9△的 3′末端 ,构建正确读码框架的融合基因 .在两个基因间引入蛋白质羟胺切割位点序列 ,转入E .coliJM10 9中 ,IPTG诱导表达 .该融合蛋白的表达量占菌体总蛋白的 2 0 %以上 ,主要以包涵体形式存在 ,盐酸羟胺切割表达产物 .分析表明 ,80 %左右的融合蛋白被裂解为GST6 9△和Gly hPTH(1 34) .经分子筛柱层析和反相层析分离纯化获得重组Gly hPTH(1 34)衍生物 ,纯度达 98%以上 ,回收率约为 10mg/升发酵液 ,分子量为 4 177,等电点 (pI)为 8 4 0 ,N端 16个氨基酸 ,除第一个为甘氨酸外 ,其余与天然hPTH(1 34)序列一致 .Western印迹结果表明 ,Gly hPTH(1 34)衍生物具有hPTH(1 34)的免疫学活性 .体外活性测定结果表明 ,Gly hPTH(1 34)衍生物能刺激人成骨细胞HOSTE85增殖、增加细胞内胶原合成、ALP活性增高和cAMP生成量增加 ,并呈量效关系 ,提示它具有与化学合成的hPTH(1 34)相同的生物学活性 ,N端多一个Gly对其活性无明显影响 .